Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

BD BACTEC FX40 Blood Culture Instrument Now Communicates with the BD EpiCenter Data Management System

Published: Saturday, June 14, 2014
Last Updated: Saturday, June 14, 2014
Bookmark and Share
Low-Volume Clinical Laboratories Now Have Access to Advanced Data Management with New Blood Culture Instrument Connectivity

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, has announced its launch of the BD BACTEC FX40 Blood Culture System with connectivity to the BD EpiCenter Microbiology Data Management System. This communication enables access to advanced reporting capabilities, connectivity to the hospital's Laboratory Information System (LIS) and access to the unique BD Blood Volume Monitoring Software.

Introduced in August 2013, the BD BACTEC FX40 Blood Culture System offers low-volume clinical laboratories the same state-of-the-art workflow and performance of the BD BACTEC FX blood culture system, with BD's exclusive vial-activated workflow. Communication with the BDEpiCenter Data Management System also provides access to the unique BD BACTEC Blood Volume Monitoring Software. This software offers automatic measurement and reporting of blood volume averages in BD BACTEC Plus Aerobic/F media bottles for patient populations. The ability to automatically track blood volumes gives laboratory professionals the confidence and ability to provide quality blood culture testing while improving their effectiveness in detecting bacteria, yeast and fungi in blood. A variety of reports can be generated to track, display and communicate average blood volumes collected from across the hospital or by a specific phlebotomist.

"We're pleased to be able to offer laboratories the convenience of a lower-volume blood culture instrument, with all of the advantages of full integration with the LIS," said Alberto Mas, President, BD Diagnostics Diagnostic Systems. "BD is committed to providing laboratory professionals with solutions that enable them to follow industry-recommended blood specimen collection best practices, including monitoring and providing feedback on collected blood volumes, and by providing a steady supply of product."

The volume of blood collected is the single most important factor affecting organism recovery in blood cultures.1 In fact, in adult blood culture specimens, recovery increases by approximately three percent for each additional milliliter of blood obtained.2 As a result, commonly accepted best practices, such as those outlined in the CLSI guidelines, call for 20 to 30 mL of blood collected per venipuncture or set, two to three sets per episode.3 Additionally, laboratory accreditation agencies, such as the College of American Pathologists, require that laboratories periodically monitor collected blood volumes and provide feedback to clinical staff.4

The BD BACTEC Blood Culture System is a fully automated microbiology growth and detection system designed to detect microbial growth from blood specimens. The BD BACTEC FX40 Instrument with connectivity to the BD EpiCenter Data Management System represents one of several new advancements in the blood culture arena for BD Diagnostics, a leader in blood culture solutions for more than 25 years. The BACTEC FX and the BD BACTEC 9000 families of continuous monitoring blood culturing instruments offer performance, safety, reliability, ease of use, media quality and service to meet the needs of today's top clinical laboratories.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Promising Drug Combination for Advanced Prostate Cancer
A new drug combination may be effective in treating men with metastatic prostate cancer. Preliminary results of this new approach are encouraging and have led to an ongoing international study being conducted in 196 hospitals worldwide.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos